Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Taiwan signs local deals for up to 20 mln COVID shots

05/30/2021 | 03:59am EDT

TAIPEI, May 30 (Reuters) - Taiwan's government has signed deals with two local companies to provide up to 20 million doses of their COVID-19 vaccines, the official Central News Agency said on Sunday, in a boost to the island's pandemic fight.

The news comes days after the Chinese-claimed island blamed Beijing week for blocking a deal earlier this year for BioNTech SE vaccines, which China denies.

After recording just a handful of daily infections for months, Taiwan is dealing with relatively large numbers of community transmissions, though infection rates are starting to fall.

It has only vaccinated around 1% of its more than 23 million people but has almost 30 million shots on order, from AstraZeneca Plc, Moderna Inc and two domestic firms.

The Central News Agency said the government had on Friday signed deals with Medigen Vaccine Biologics Corp and United Biomedical Inc for five million doses each, and had oral agreements for another five million each, for a total of 20 million shots.

Medigen confirmed the details in a statement to the stock exchange while the government's central epidemic command centre said it would issue a statement later. United Biomedical did not immediately respond to a request for comment.

However, neither shot has yet been formally approved for use and both are still undergoing tests, which Taiwan's government says are going well.

Earlier on Sunday, Health Minister Chen Shih-chung said Taiwan has not given up hope of eventually getting COVID-19 vaccines from Germany's BioNTech.

Shanghai Fosun Pharmaceutical Group Co has a contract with BioNTech to sell the vaccines in Greater China, including to Taiwan, but Taiwan's government says it will only deal with Germany's BioNTech directly and does not trust vaccines from China.

Outside of Greater China, BioNTech has partnered with Pfizer Inc..

Taiwan is under its second-highest level of curbs to stop the spread of infections, including limiting personal gatherings and closing entertainment venues.

Chen said the task was to ensure those measures were being properly enforced, adding, "At present there are no plans or intentions for a lockdown."

Taiwan reported 355 domestic COVID-19 cases on Sunday, down from 486 on Saturday. Total daily cases peaked on May 17 and have been falling since Friday. (Reporting by Ben Blanchard; editing by William Mallard and Emelia Sithole-Matarise)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.11% 8268 Delayed Quote.12.89%
BIONTECH SE 5.04% 328.35 Delayed Quote.302.78%
MEDIGEN VACCINE BIOLOGICS CORPORATION -0.89% 277.5 End-of-day quote.169.42%
MODERNA, INC. 2.30% 353.6 Delayed Quote.238.47%
MSCI TAIWAN (STRD) -0.74% 690.203 Real-time Quote.15.72%
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 9.54% 81.88 End-of-day quote.51.66%
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
07/28SHANGHAI FOSUN PHARMACEUTICAL : An announcement has just been published by the i..
PU
07/19Sisram Medical Seeks $80 Million in Private Placement; Shares Fall 6%
MT
07/19SHANGHAI FOSUN PHARMACEUTICAL : Voluntary announcement entering into the placing..
PU
07/19SHANGHAI FOSUN PHARMACEUTICAL (GROUP : Ex-dividend day for final dividend
FA
07/14SINOVAC BIOTECH : Fosun-BioNTech COVID-19 vaccine completes China regulator revi..
RE
07/14MARKET CHATTER : BioNTech's COVID-19 Vaccine Advances to Administration Review i..
MT
07/14SHANGHAI FOSUN PHARMACEUTICAL : Poll results of the resolution proposed at the 2..
PU
07/13Hong Kong says no personal data shared in vaccine deal with Fosun
RE
07/13Sisram Medical Limited completed the acquisition of Shanghai Foshion Medical ..
CI
07/12Politics, health collided in Taiwan's tortured BioNTech vaccine talks
RE
More news
Financials
Sales 2021 40 184 M 6 220 M 6 220 M
Net income 2021 4 372 M 677 M 677 M
Net Debt 2021 15 917 M 2 464 M 2 464 M
P/E ratio 2021 48,2x
Yield 2021 0,63%
Capitalization 165 B 25 482 M 25 485 M
EV / Sales 2021 4,49x
EV / Sales 2022 3,98x
Nbr of Employees 32 258
Free-Float 58,8%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | 600196 | CNE000000X38 | MarketScreener
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 81,88 CNY
Average target price 57,08 CNY
Spread / Average Target -30,3%
EPS Revisions
Managers and Directors
Xiao Hui Guan Executive President & Chief Financial Officer
Yu Qing Chen Co-President
Ke Xin Wang Co-President
Dong Ming Li Co-President
Yi Fang Wu Chairman